Fox Run Management, L.L.C. Veracyte, Inc. Transaction History
Fox Run Management, L.L.C.
- $433 Million
- Q3 2024
A detailed history of Fox Run Management, L.L.C. transactions in Veracyte, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 9,011 shares of VCYT stock, worth $386,031. This represents 0.07% of its overall portfolio holdings.
Number of Shares
9,011
Previous 9,627
6.4%
Holding current value
$386,031
Previous $208,000
47.12%
% of portfolio
0.07%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$334 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$332 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$215 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$211 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$181 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.07B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...